Scanbio Denmark ApS: Financial statements 2022
CVR: 42107654
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 8,062,158 and a net result of DKK 3,884,563 compared with DKK 447,682 the year before. That is an increase of 224.5% compared with the year before. Equity in the 2022 report amounted to DKK 4,372,245. The solvency ratio was 15.3%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 8,062,158
- Profit/Loss
- DKK 3,884,563
- Equity
- DKK 4,372,245
- Total Assets
- DKK 28,500,314
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 8.1 mio. | 3.9 mio. | 4.4 mio. | 4 |
| 2021 | - | 2.5 mio. | 448 t. | 488 t. | 3 |
Official annual report
Keep an eye on Scanbio Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Scanbio Denmark ApS has published its interim report for the period February 8, 2021 – December 31, 2021.
About Scanbio Denmark ApS
Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. According to the 2025 annual report, the company had an average of 6 employees. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity in the 2025 report amounted to DKK 10,249,140.